Depression Side Effect Labeling Awareness Act of 2019
Latest action · Sep 20, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 19, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Depression Side Effect Labeling Awareness Act of 2019
This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
Cosponsors 7
Members who signed on, in the order they did. Signatures ran from Sep 25, 2019 to Jul 21, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-TX | Sheila Jackson Lee | Sep 25, 2019 | |
| D-MI | Debbie Dingell | Oct 4, 2019 | |
| D-IN | André Carson | Nov 12, 2019 | |
| D-PA | Susan Wild | Dec 4, 2019 | |
| D-MS | Bennie G. Thompson | Dec 9, 2019 | |
| D-FL | Alcee L. Hastings | Jan 21, 2020 | |
| D-GU | Michael F. Q. San Nicolas | Jul 21, 2020 |
Actions 3
Everything that happened, newest first.
- Sep 20, 2019Referred to the Subcommittee on Health.
- Sep 19, 2019Introduced in House
- Sep 19, 2019Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Sep 19, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.